Suchergebnisse - (Person:"Guo, Ensong")

PubPharm (7)

1

Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Xiao, R. | You, L. | Zhang, L. | +26

2

AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway

enthalten in: Cancer letters | 2022

von Liu, C. | Huang, Y. | Qin, T. | +23

3

WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade

enthalten in: Cancer science | 2021

von Wu, X. | Kang, X. | Zhang, X. | +12

4

MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis

enthalten in: Oncogene | 2020

von Sun, C. | Li, X. | Guo, E. | +16

5

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2016

von Guo, L. | Zhou, B. | Liu, Z. | +7

6

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

enthalten in: International journal of oncology | 2016

von Zhou, B. | Sun, C. | Li, N. | +10

7

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells

enthalten in: Oncology research | 2016

von Lu, H. | Sun, C. | Zhou, T. | +11

1
[1]